Ginny Mason: The Importance of Monitoring Blood Clot Risks in Cancer Patients
Aug 30, 2025, 17:51

Ginny Mason: The Importance of Monitoring Blood Clot Risks in Cancer Patients

Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on LinkedIn:

“Cancer Patients are at greater risk for blood clots, yet many patients aren’t aware of this increased risk. It’s especially important that Clinical Trials monitor and report accurate results.”

Read More.

More posts featuring Ginny Mason on OncoDaily.